The Gross Margin of Eris Lifesciences Ltd (ERIS.NS) is 79.94%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-03-31 | 79.94% |
| 2023-03-31 | 78.29% |
| 2022-03-31 | 80.23% |
| 2021-03-31 | 79.62% |
| 2020-03-31 | 82.78% |
| 2019-03-31 | 83.69% |
| 2018-03-31 | 82.83% |
| 2017-03-31 | 81.44% |
| 2016-03-31 | 82.54% |
| 2015-03-31 | 81.84% |